Healthcare Triangle announced two material agreements affecting prior and pending M&A transactions. The company reached a make-whole Securities Exchange Agreement with SecureKloud, issuing 2,828,167 common shares in exchange for the return of Series B Preferred Stock rendered impractical to convert after reverse splits; closing requires stockholder approval and the shares will be registered for resale. Separately, Healthcare Triangle amended the Teyame AI share purchase terms to provide $12 million in restricted common stock and 18,000 Series C Preferred shares, with conversion only after stockholder approval; any issuance above 19.99% will be delivered via a pre-funded warrant, and a 5,000-share preferred earnout is tied to 2026 and 2027 performance.
Agreement 1: Healthcare Triangle to Issue 2.83M Shares to SecureKloud in Make-Whole Exchange After Reverse Splits
- Agreement type: Securities Exchange Agreement (make-whole share issuance)
- Counterparty: SecureKloud Technologies
- Signed / Effective: Jun 24 2026 / same
- Duration / Termination: At will
- Reason: Settle consideration after reverse splits; make-whole for SecureKloud
Agreement 2: Healthcare Triangle Revises Teyame AI Deal: $12M Stock, 18,000 Preferred Shares, PFW Structure
- Agreement type: Amendment No. 1 to Share Purchase Agreement (revised acquisition consideration)
- Counterparty: Teyame AI
- Signed / Effective: Jun 25 2026 / same
- Duration / Termination: At will
- Reason: Revise acquisition consideration and align with Nasdaq ownership limits
Original SEC Filing:
This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.